Merck

-4.8%

More reviews (1)

Live  

Merck is a global pharmaceutical and chemical company founded in 1668 in Darmstadt, Germany. It was originally a supplier of traditional chemicals, but later expanded into pharmaceuticals, life sciences, and performance materials. Merck is also known as Merck KGaA, as it is a family-owned company with around 50% of its shares controlled by the descendants of its founder, Friedrich Jacob Merck.
The company has a strong presence in Europe and the United States, as well as in emerging markets such as China, India, and Latin America. It employs over 57,000 people and generates annual revenues of around 14 billion euros.
Merck's pharmaceutical division focuses on developing and commercializing innovative medicines in various therapeutic areas, including oncology, neurology, immunology, and cardiovascular diseases. Its life sciences division provides products and services for research, development, and production in the biopharmaceutical and biotechnological industries. The performance materials division provides materials and technologies for various industries, including healthcare, electronics, coatings, and cosmetics.
The company's mission is to "empower scientists and engineers to create and make life-changing innovations that improve people's lives." It is committed to sustainability and has set ambitious targets to reduce its environmental impact, promote diversity and inclusion, and improve access to healthcare for underserved populations.
Merck is also actively involved in corporate social responsibility initiatives, including providing disaster relief and supporting education and community development programs around the world.

Merck is a big company that helps people stay healthy. Imagine it like a superhero for health! They create medicines and vaccines that help fight off diseases, which is very important for keeping people safe and well.
So, how does Merck make money? When doctors and hospitals use their medicines and vaccines to help patients, they pay Merck for them. It’s kind of like how you buy a toy from a store. The more people that need their medicines, the more money the company makes.
Now, why is Merck successful? Well, they do a lot of research to discover new medicines that can help with different health problems. They also try to make sure their products are safe and effective for everyone. Plus, as more people in the world need healthcare, Merck’s work becomes more important.
As for the future, Merck is likely to stay successful because they are always working on new ideas and treatments. They invest a lot in science and innovation, which means they are always looking for better ways to help people. And with new challenges, like new diseases, there will always be a need for good medicines, so Merck will keep playing a key role in health care.

TWVyY2sgaX MgYSBnbG9i YWwgcGhhcm 1hY2V1dGlj YWwgYW5kIG hlYWx0aGNh cmUgY29tcG FueSB0aGF0 IGhhcyBiZW VuIGluIG9w ZXJhdGlvbi Bmb3Igb3Zl ciAzNTAgeW VhcnMsIG1h a2luZyBpdC BvbmUgb2Yg dGhlIG9sZG VzdCBhbmQg bGFyZ2VzdC BwaGFybWFj ZXV0aWNhbC Bjb21wYW5p ZXMgaW4gdG hlIHdvcmxk LiBJdCBoYX MgYSBsb25n IGhpc3Rvcn kgb2YgaW5u b3ZhdGlvbi BhbmQgcmVz ZWFyY2gsIG xlYWRpbmcg dG8gdGhlIG RldmVsb3Bt ZW50IG9mIG 51bWVyb3Vz IG1lZGljYX Rpb25zIGFu ZCB2YWNjaW 5lcyB0aGF0 IGhhdmUgc2 lnbmlmaWNh bnRseSBpbX Byb3ZlZCBn bG9iYWwgaG VhbHRoLiBU aGUgY29tcG FueSBhbHNv IGhhcyBhIH N0cm9uZyBj b21taXRtZW 50IHRvIHN1 c3RhaW5hYm lsaXR5IGFu ZCBjb3Jwb3 JhdGUgcmVz cG9uc2liaW xpdHksIGVt cGhhc2l6aW 5nIGV0aGlj YWwgYnVzaW 5lc3MgcHJh Y3RpY2VzIG FuZCBnaXZp bmcgYmFjay B0byB0aGUg Y29tbXVuaX RpZXMgaW4g d2hpY2ggaX Qgb3BlcmF0 ZXMuIE1lcm NrIGlzIGFs c28ga25vd2 4gZm9yIGl0 cyBkaXZlcn NlIHdvcmtm b3JjZSBhbm QgaW5jbHVz aXZlIGN1bH R1cmUsIHdp dGggYSBmb2 N1cyBvbiBw cm9tb3Rpbm cgZGl2ZXJz aXR5IGFuZC BpbmNsdXNp b24gaW4gYW xsIGFzcGVj dHMgb2YgaX RzIG9wZXJh dGlvbnMuIE FkZGl0aW9u YWxseSwgTW VyY2sgaGFz IGEgc3Ryb2 5nIGZvY3Vz IG9uIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBh bmQgaW52ZX N0cyBoZWF2 aWx5IGluIG 5ldyB0ZWNo bm9sb2dpZX MgYW5kIGlu bm92YXRpb2 5zIHRvIGNv bnRpbnVlIG RyaXZpbmcg c2NpZW50aW ZpYyBhZHZh bmNlbWVudH MgaW4gdGhl IGhlYWx0aG NhcmUgaW5k dXN0cnkuIE 92ZXJhbGws IE1lcmNrJ3 MgZGVkaWNh dGlvbiB0by BpbXByb3Zp bmcgZ2xvYm FsIGhlYWx0 aCwgY29tbW l0bWVudCB0 byBldGhpY2 FsIGFuZCBy ZXNwb25zaW JsZSBidXNp bmVzcyBwcm FjdGljZXMs IGFuZCBlbX BoYXNpcyBv biBkaXZlcn NpdHkgYW5k IHJlc2Vhcm NoIG1ha2Ug aXQgYSB1bm lxdWUgYW5k IHJlc3BlY3 RlZCBjb21w YW55IGluIH RoZSBwaGFy bWFjZXV0aW NhbCBpbmR1 c3RyeS4=

VGhlIE1lcm NrIGNvbXBh bnkgaXMgYS BnbG9iYWwg cGhhcm1hY2 V1dGljYWwg Y29tcGFueS B0aGF0IG9w ZXJhdGVzIH VuZGVyIGEg dHJhZGl0aW 9uYWwgYnVz aW5lc3MgbW 9kZWwuIFRo aXMgbWVhbn MgdGhhdCBp dCBjcmVhdG VzLCBtYW51 ZmFjdHVyZX MsIGFuZCBt YXJrZXRzIH ByZXNjcmlw dGlvbiBkcn VncywgdmFj Y2luZXMsIG Jpb2xvZ2lj IHRoZXJhcG llcywgYW5p bWFsIGhlYW x0aCBwcm9k dWN0cywgYW 5kIG92ZXIt dGhlLWNvdW 50ZXIgbWVk aWNhdGlvbn MuIFRoZSBj b21wYW55J3 MgbWFpbiBy ZXZlbnVlIH NvdXJjZSBp cyB0aHJvdW doIHRoZSBz YWxlIG9mIH RoZXNlIHBy b2R1Y3RzIH RvIGhlYWx0 aCBjYXJlIH Byb2Zlc3Np b25hbHMgYW 5kIGRpcmVj dGx5IHRvIG NvbnN1bWVy cy4gTWVyY2 sgYWxzbyBl bmdhZ2VzIG luIHJlc2Vh cmNoIGFuZC BkZXZlbG9w bWVudCBvZi BuZXcgbWVk aWNpbmVzLC BhbmQgaGFz IGEgbGFyZ2 UgcG9ydGZv bGlvIG9mIH Byb2R1Y3Rz IGZvY3VzZW Qgb24gdGhl cmFwZXV0aW MgYXJlYXMg c3VjaCBhcy BvbmNvbG9n eSwgY2FyZG lvdmFzY3Vs YXIgZGlzZW FzZXMsIHZh Y2NpbmVzLC BpbmZlY3Rp b3VzIGRpc2 Vhc2VzLCBh bmQgYW5pbW FsIGhlYWx0 aC4gSW4gYW RkaXRpb24g dG8gZGV2ZW xvcGluZyBh bmQgc2VsbG luZyBpdHMg b3duIHByb2 R1Y3RzLCBN ZXJjayBhbH NvIGVuZ2Fn ZXMgaW4gcG FydG5lcnNo aXBzIGFuZC Bjb2xsYWJv cmF0aW9ucy B3aXRoIG90 aGVyIGNvbX BhbmllcyBp biB0aGUgaG VhbHRoY2Fy ZSBpbmR1c3 RyeS4=

AI can impact Merck and its competitive positioning across various dimensions, though the extent of the threat can vary based on specific circumstances.
1. Substitution: AI technologies can potentially lead to the development of new products or therapies that offer alternative solutions to traditional pharmaceuticals. For example, AI-driven drug discovery platforms can identify novel compounds faster and more efficiently than traditional methods. If competitors successfully leverage AI to develop more effective treatments, Merck could face pressure on its product offerings.
2. Disintermediation: AI can streamline processes and reduce the need for certain intermediaries in the healthcare supply chain. For instance, telemedicine and digital health platforms can create direct interactions between patients and healthcare providers, bypassing traditional routes. If patients increasingly rely on AI-driven solutions for diagnosis and treatment recommendations, Merck might see shifts in how its products are marketed and accessed.
3. Margin Pressure: The use of AI in drug development and manufacturing can lead to cost reductions, which may create margin pressure for established pharmaceutical companies like Merck. If competitors utilize AI to produce similar products at a lower cost or bring drugs to market more quickly, Merck may need to adjust its pricing strategy or invest in technology to maintain its margins.
Overall, while AI does pose potential threats to Merck regarding substitution, disintermediation, and margin pressure, it can also represent an opportunity for the company to enhance its own capabilities, drive innovation, and improve efficiencies across its operations. The net effect will depend on how well Merck adapts and integrates AI into its strategies.

The sensitivity of Merck & Co.’s earnings, cash flow, and valuation to changes in interest rates can be analyzed through several factors:
1. Earnings Sensitivity: Merck’s earnings are indirectly sensitive to interest rates. Higher interest rates can lead to increased borrowing costs if the company needs to finance operations, research and development, or acquisitions. Additionally, higher rates may constrain consumer spending, potentially impacting sales of pharmaceuticals. Conversely, lower interest rates may facilitate capital investment and expansion.
2. Cash Flow Sensitivity: Merck’s cash flow can be affected by interest rates primarily through its debt obligations. If interest rates rise, the cost of servicing any variable-rate debt will increase, potentially reducing free cash flow. Lower rates can positively impact cash flow by lowering interest expenses. Moreover, changes in interest rates can influence the timing and amount of cash flows received from customers, especially in a tight economic environment.
3. Valuation Sensitivity: The valuation of Merck, like other companies, is sensitive to changes in interest rates due to the discounted cash flow (DCF) methodology generally used to estimate a company’s value. When interest rates rise, the discount rate used in DCF calculations increases, which can lead to a lower present value of future cash flows, thus reducing the company’s valuation. Conversely, lower interest rates can enhance valuation by lowering the discount rate and increasing the present value of future cash flows.
In summary, while Merck’s operations can be influenced by changes in interest rates, the sensitivity may not be as pronounced as in highly leveraged companies. The impact on earnings, cash flow, and valuation will depend on the company’s debt levels, capital structure, and market dynamics.

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvNX owZmx5ZTJB cEZ0SVRRMD FCZFkud2Vi cCIgYWx0PS JNZXJjayIg dGl0bGU9Ik 1lcmNrIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTkwIHdp ZHRoPTkwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IE 1lcmNrPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TpSBHZXQg b3VyIGZyZW UgZUJvb2sg bm93OiA8aT 4iVGhlIENo ZWNrbGlzdC BWYWx1ZSBJ bnZlc3Rvci DigJQgQSBT bWFydGVyIF dheSB0byBQ aWNrIFN0b2 NrcyI8L2k+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvcD4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwhLS0K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nbW FyZ2luLXRv cDogMTJweD sgZm9udC1z aXplOiAxM3 B4OyBjb2xv cjogIzQ0ND snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgU2lnbiB1 cCBub3cgYW 5kIGdldCBv dXIgZnJlZS BlQm9vayAK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDxi PlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3M8L2I+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxNnB4OyBm b250LXNpem U6IDE0cHg7 IGNvbG9yOi AjNDQ0OyBm b250LWZhbW lseTogLWFw cGxlLXN5c3 RlbSwgQmxp bmtNYWNTeX N0ZW1Gb250 LCBTZWdvZS BVSSwgUm9i b3RvLCBIZW x2ZXRpY2Eg TmV1ZSwgc2 Fucy1zZXJp ZjsgbGluZS 1oZWlnaHQ6 IDEuNjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgSG F2ZSB5b3Ug aGVhcmQgYW JvdXQgb3Vy IHNob3J0ID xzdHJvbmcg c3R5bGU9J2 ZvbnQtd2Vp Z2h0OiA2MD A7Jz5EYWls eSBWaWRlby BOZXdzbGV0 dGVyPC9zdH Jvbmc+Pwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naH R0cHM6Ly93 d3cuaW5zaW dodGZ1bHZh bHVlLmNvbS 9uZXdzbGV0 dGVyLnBocC cgdGFyZ2V0 PSdfYmxhbm snIHN0eWxl PSdjb2xvcj ogIzAwN0JG RjsgdGV4dC 1kZWNvcmF0 aW9uOiBub2 5lOyBmb250 LXdlaWdodD ogNTAwOyBt YXJnaW4tbG VmdDogNnB4 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgRm luZCBvdXQg bW9yZQogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgLS0+Ci AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgIAog ICAgICAgIA ogICAgICAg IDxzcGFuIG NsYXNzPSdi bHVycmVkLX RleHQnPgog ICAgICAgIC AgICBUV1Z5 WTJzZ0ptIE Z0Y0RzZ1Ey OHUgTENCcm JtOTNiaSBC aGN5Qk5VMF FnIGIzVjBj MmxrWlMgQj BhR1VnVlc1 cCBkR1ZrSU ZOMFlYIFJs Y3lCaGJtUW cgUTJGdVlX UmhMQyBCcG N5QnZibVVn IGIyWWdkR2 hsSUcgeGhj bWRsYzNRZy BjR2hoY20x aFkyIFYxZE dsallXd2cg WTI5dGNHRn VhVyBWeklH bHVJSFJvIF pTQjNiM0pz WkMgNGdTR1 Z5WlNCaCBj bVVnYzI5dF pTIEJwYm5S bGNtVnogZE dsdVp5Qm1Z VyBOMGN5Qm hZbTkxIGRD QjBhR1VnWT IgOXRjR0Z1 ZVRvOCBZbk krTVM0Z1NH IGx6ZEc5eW VUb2cgVFdW eVkyc2dkMi BGeklHOXlh V2RwIGJtRn NiSGtnWm0g OTFibVJsWk NCcCBiaUF4 T0RreElHIE Z6SUhSb1pT QlYgTGxNdU lITjFZbiBO cFpHbGhjbm tnIGIyWWdk R2hsSUUgZG xjbTFoYmlC TiBaWEpqYX lCbVlXIDFw YkhrZ1kyOX QgY0dGdWVT d2dkMiBocF kyZ2daR0Yw IFpYTWdZbU ZqYXkgQjBi eUF4TmpZNC BMaUJVYUdV Z1ZTIDVUTG lCaWNtRnUg WTJnZ1ltVm pZVyAxbElH bHVaR1Z3IF pXNWtaVzUw SUcgUjFjbW x1WnlCWCBi M0pzWkNCWF lYIElnU1M0 OFluSSsgTW k0Z1NXNXVi MyBaaGRHbH Ziam9nIFRX VnlZMnNnYU cgRnpJR0ps Wlc0ZyBjbV Z6Y0c5dWMy IGxpYkdVZ1 ptOXkgSUhO bGRtVnlZVy B3Z1ozSnZk VzVrIFluSm xZV3RwYm0g Y2daSEoxWj NNZyBZVzVr SUhaaFkyIE 5wYm1WeklH OTIgWlhJZ2 RHaGxJSCBs bFlYSnpMQ0 JwIGJtTnNk V1JwYm0gY2 dkR2hsSUdS bCBkbVZzYj NCdFpXIDUw SUc5bUlIUm 8gWlNCbWFY SnpkQyBCdF pXRnpiR1Z6 IElIWmhZMk 5wYm0gVWdh VzRnZEdobC BJREU1TmpC ekxDIEIwYU dVZ1NGQlcg SUhaaFkyTn BibSBVZ1Iy RnlaR0Z6IG FXd3NJR0Z1 WkMgQjBhR1 VnWTJodiBi R1Z6ZEdWeW IyIHd0Ykc5 M1pYSnAgYm 1jZ1pISjFa eSBCYWIyTn ZjaTQ4IFlu SStNeTRnVW 0gVnpaV0Z5 WTJnZyBSbT lqZFhNNklF IDFsY21Ock lHbHUgZG1W emRITWdhRy BWaGRtbHNl U0JwIGJpQn laWE5sWVgg SmphQ0JoYm 1RZyBaR1Yy Wld4dmNHID FsYm5RdUlG Um8gWlNCam IyMXdZVyA1 NUlHaGhjeU JoIElHeHZi bWN0YzMgUm hibVJwYm1j ZyBZMjl0Yl dsMGJXIFZ1 ZENCMGJ5Qm ggWkhaaGJt TnBibSBjZ2 FHVmhiSFJv IFkyRnlaU0 IwYUggSnZk V2RvSUhOai BhV1Z1WTJV Z1lXIDVrSU doaGN5Qmgg SUdScGRtVn ljMiBVZ2NH bHdaV3hwIG JtVWdkR2ho ZEMgQnBibU 5zZFdSbCBj eUIwY21WaG RHIDFsYm5S eklHWnYgY2 lCa2FXRmla WCBSbGN5d2 dZMkZ1IFky VnlMQ0JoYm 0gUWdhVzVt WldOMCBhVz kxY3lCa2FY IE5sWVhObG N5NDggWW5J K05DNGdSMi B4dlltRnNJ RkpsIFlXTm 9PaUJOWlgg SmpheUJ2Y0 dWeSBZWFJs Y3lCcGJpIE J0YjNKbElI Um8gWVc0Z0 1UUXdJRyBO dmRXNTBjbW xsIGN5d2di V0ZyYVcgNW 5JR2wwY3lC dyBjbTlrZF dOMGN5IEJo WTJObGMzTn AgWW14bElI UnZJRyBFZ2 MybG5ibWxt IGFXTmhibl FnY0cgOXlk R2x2YmlCdi BaaUIwYUdV Z1oyIHh2WW 1Gc0lIQnYg Y0hWc1lYUn BiMiA0dUlF bDBjeUJuIG JHOWlZV3dn Y0ggSmxjMl Z1WTJVZyBZ V3hzYjNkek lHIFp2Y2lC a2FYWmwgY2 5ObElHMWhj bSB0bGRITW dZVzVrIElI QmhjblJ1Wl ggSnphR2x3 Y3k0OCBZbk krTlM0Z1Ey IDl0YldsMG JXVnUgZENC MGJ5QlRkWC BOMFlXbHVZ V0pwIGJHbD BlVG9nVFcg VnlZMnNnYU dGeiBJRzFo WkdVZ2MzIF J5YVdSbGN5 QnAgYmlCem RYTjBZVyBs dVlXSnNaU0 J3IGNtRmpk R2xqWlggTX NJR0ZwYlds dSBaeUIwYn lCeVpXIFIx WTJVZ2FYUn ogSUdWdWRt bHliMiA1dF pXNTBZV3dn IFptOXZkSE J5YVcgNTBJ R0Z1WkNCbS BiMk4xYzJs dVp5IEJ2Ym lCeVpYTncg YjI1emFXSn NaUyBCemIz VnlZMmx1IF p5d2daVzVs Y20gZDVJR1 ZtWm1saiBh V1Z1WTNrc0 lHIEZ1WkNC M1lYTjAgWl NCeVpXUjFZ MyBScGIyNG dhVzRnIGFY UnpJRzFoYm 4gVm1ZV04w ZFhKcCBibW NnY0hKdlky IFZ6YzJWek xqeGkgY2o0 MkxpQk5aWC BKamF5Qk5Z VzUxIFlXdz ZJRTFsY20g TnJJSEIxWW 14cCBjMmhs Y3lCMGFHIF VnVFdWeVky c2cgVFdGdW RXRnNMQyBC aElIZHBaR1 ZzIGVTQnla WE53WlcgTj BaV1FnYldW ayBhV05oYk NCeVpXIFps Y21WdVkyVW cgWW05dmF5 QjFjMiBWa0 lHSjVJR2hs IFlXeDBhR0 5oY20gVWdj SEp2Wm1Wei BjMmx2Ym1G c2N5IDRnU1 hRZ2FHRnog SUdKbFpXNG dhVyA0Z2NI VmliR2xqIF lYUnBiMjRn YzIgbHVZMl VnTVRnNSBP U0JoYm1RZ2 FYIE1nWVha aGFXeGggWW 14bElHbHVJ RyAxMWJIUn BjR3hsIElH eGhibWQxWV cgZGxjeTQ4 WW5JKyBOeT RnUTI5eWNH IDl5WVhSbE lGTnYgWTJs aGJDQlNaWC BOd2IyNXph V0pwIGJHbD BlVG9nVFcg VnlZMnNnYV hNZyBhVzUy YjJ4MlpXIF FnYVc0Z2Rt RnkgYVc5MW N5QndhRyBs c1lXNTBhSE p2IGNHbGpJ R2x1YVggUn BZWFJwZG1W eiBMQ0JwYm 1Oc2RXIFJw Ym1jZ1lXTm ogWlhOeklI UnZJRyAxbF pHbGphVzVs IGN5QmhibV FnYUcgVmhi SFJvWTJGeS BaU0J3Y205 bmNtIEZ0Y3 lCcGJpQjEg Ym1SbGNuTm xjbiBabFpD QmpiMjF0IG RXNXBkR2xs Y3kgQmhjbT kxYm1RZyBk R2hsSUhkdm NtIHhrTGlC VWFHVjUgSU dadlkzVnpJ RyA5dUlHMW hhMmx1IFp5 Qm9aV0ZzZE cgaGpZWEps SUcxdiBjbV VnWlhGMWFY IFJoWW14bE lHRnUgWkNC aFkyTmxjMy BOcFlteGxM anhpIGNqND RMaUJCYm0g bHRZV3dnU0 dWaCBiSFJv T2lCSmJpIE JoWkdScGRH bHYgYmlCMG J5Qm9kVyAx aGJpQndhR0 Z5IGJXRmpa WFYwYVcgTm hiSE1zSUUx bCBjbU5ySU dseklHIEVn YkdWaFpHVn kgSUdsdUlI WmxkRyBWeW FXNWhjbmtn IGJXVmthV0 5wYm0gVXVJ RTFsY21Oci BJRUZ1YVcx aGJDIEJJWl dGc2RHZ2cg YjJabVpYSn pJSCBaaFky TnBibVZ6IE lHRnVaQ0J3 YUcgRnliV0 ZqWlhWMCBh V05oYkhNZ1 ptIDl5SUd4 cGRtVnogZE c5amF5Qmhi bSBRZ1kyOX RjR0Z1IGFX OXVJR0Z1YV cgMWhiSE1z SUdOdiBibl J5YVdKMWRH IGx1WnlCem FXZHUgYVda cFkyRnVkRy B4NUlIUnZJ SFpsIGRHVn lhVzVoY24g a2dZMkZ5Wl M0OCBZbkkr T1M0Z1UzIF J5YjI1bklG QnAgY0dWc2 FXNWxPaSBC VWFHVWdZMj l0IGNHRnVl U0JvWVggTW dZU0J5YjJK MSBjM1FnY0 dsd1pXIHhw Ym1VZ2IyWW cgWkhKMVoz TWdhVyA0Z2 RtRnlhVzkx IGN5QnpkR0 ZuWlggTWdi MllnWkdWMi BaV3h2Y0cx bGJuIFFzSU dadlkzVnog YVc1bklHOX VJRyBGeVpX RnpJSE4xIF kyZ2dZWE1n YjIgNWpiMn h2WjNrcyBJ SFpoWTJOcG JtIFVnWkdW MlpXeHYgY0 cxbGJuUXNJ RyBGdVpDQn BibVpsIFkz UnBiM1Z6SU cgUnBjMlZo YzJWeiBMaU JVYUdseklH IE52Ym5ScG JuVnYgZFhN Z2FXNXViMy BaaGRHbHZi aUJ3IGJHRj VjeUJoSUcg TnlkV05wWV d3ZyBjbTlz WlNCcGJpIE JwZEhNZ1oz SnYgZDNSb0 xqeGljaiA0 eE1DNGdSVz F3IGJHOTVa V1VnUTMgVn NkSFZ5WlRv ZyBUV1Z5WT JzZ2FYIE1n YTI1dmQyNG cgWm05eUlH bDBjeSBCam IyMXRhWFJ0 IFpXNTBJSF J2SUggZHZj bXR3YkdGai BaU0JrYVha bGNuIE5wZE hrZ1lXNWsg SUdWdGNHeH ZlVyBWbElI ZGxiR3d0IF ltVnBibWN1 SUYgUm9aU0 JqYjIxdyBZ VzU1SUdWdG NHIGhoYzJs NlpYTWcgWV NCamRXeDBk WCBKbElHOW 1JR2x1IFky eDFjMmx2Ym kgQmhibVFn YzNWdyBjRz l5ZEN3Z2Mz IFJ5YVhacG JtY2cgZEc4 Z1kzSmxZWC BSbElHRnVJ R1Z1IGRtbH liMjV0Wlcg NTBJSGRvWl hKbCBJR1Z0 Y0d4dmVXIF ZsY3lCallX NGcgZEdoeW FYWmxMaiB4 aWNqNVVhR1 Z6IFpTQmhj M0JsWTMgUn pJR2hwWjJo cyBhV2RvZE NCTlpYIEpq YStLQW1YTW cgYzJsbmJt bG1hVyBOaG JuUWdhVzF3 IFlXTjBJRz l1SUcgaGxZ V3gwYUdOaC BjbVVzSUhK bGMyIFZoY2 1Ob0xDQmgg Ym1RZ1kyOX ljRyA5eVlY UmxJSEpsIG MzQnZibk5w WW0gbHNhWF I1TGp4aSBj ajQ9CiAgIC AgICAgPC9z cGFuPgogIC AgICAgIAog ICAgICAgIA ==